CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
2.215
+0.005 (0.23%)
Apr 29, 2025, 4:00 PM EDT - Market closed
CollPlant Biotechnologies Employees
CollPlant Biotechnologies had 57 employees as of December 31, 2024. The number of employees decreased by 18 or -24.00% compared to the previous year.
Employees
57
Change (1Y)
-18
Growth (1Y)
-24.00%
Revenue / Employee
$9,035
Profits / Employee
-$291,386
Market Cap
25.37M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
CLGN News
- 14 days ago - CollPlant's Collink.3D® BioInks and Technologies Offer a Relevant and Timely Solution to FDA's Plan to Reduce Animal Testing in Preclinical Safety Studies - PRNewsWire
- 4 weeks ago - CollPlant Biotechnologies Ltd. (CLGN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - COLLPLANT BIOTECHNOLOGIES REPORTS 2024 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE - PRNewsWire
- 5 weeks ago - COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION - PRNewsWire
- 2 months ago - CollPlant Expands Distribution for its VergenixSTR Product in Europe and Asia - PRNewsWire
- 2 months ago - CollPlant Biotechnologies Provides a Corporate Update - PRNewsWire
- 5 months ago - CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - COLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - PRNewsWire